TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/29/23 17:51 | 3/27/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Markison Brian A | MA | D | S | -1,078 | 81.13 | 0 | -13 | -41 | 19 | D | |||||||||||||||
9/12/22 16:30 | 9/8/22 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Markison Brian A | MA | D | M.d | 450 | 18.40 | 0 | 24 | 300 | 33 | D | |||||||||||||||
9/12/22 16:30 | 9/8/22 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Markison Brian A | MA | D | S.d | -3,522 | 84.24 | 0 | -42 | -56 | 33 | D | |||||||||||||||
9/8/22 16:30 | 9/6/22 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Markison Brian A | MA | D | M.d | 33 | 19.78 | 0 | 2 | 4 | 50 | D | |||||||||||||||
9/8/22 16:30 | 9/6/22 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Markison Brian A | MA | D | S.d | -133 | 78.50 | 0 | -2 | -3 | 50 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |